Denver-based analytics and hospital company RxRevu has secured $15 million in Series A funding, according to company database Crunchbase, topping the city’s recent funding headlines. The cash infusion was announced June 4 and led by UCHealth.
According to its Crunchbase profile, "RxRevu, Inc. is a physician-founded organization on a mission to become the leader in prescription decision support, to help prescribers identify the most cost-effective medication using personalized factors. RxRevu was referred to as the “Google of Drugs” by CNBC and is currently working with health systems, cost transparency companies and electronic health records (EHR) vendors. RxREVU’s Prescription Decision Support platform, RxCheck, is a FHIR (Fast Healthcare Interoperability Resources)-enabled Prescription Decision Support application."
The six-year-old company has raised five previous funding rounds, including a $4.7 million round in 2017.
The round brings total funding raised by Denver companies in health care over the past month to $29 million. The local health care industry has produced 29 funding rounds over the past year, raking in a total of $762 million in venture funding.
In other local funding news, cannabis and management consulting company Medicine Man Technologies announced a $14 million post IPO equity funding round on June 6, financed by Dye Capital & Company.
According to Crunchbase, "Medicine Man Technologies (symbol: MDCL) offers full-service cannabis consulting and licensing of our state-of-the-art, turnkey cultivation and dispensary operating solutions. It represents and licenses the cultivation and dispensary IP of Medicine Man, a prominent Tier III Colorado operator."
The company also raised a $1 million post IPO equity round in 2017.
This story was created automatically using local investment data, then reviewed by an editor. Click here for more about what we're doing. Got thoughts? Go here to share your feedback.
